Abstract
Miltefosine has antifungal properties and potential for development as a therapeutic for invasive fungal infections. However, its mode of action in fungi is poorly understood. We demonstrate that miltefosine is rapidly incorporated into yeast, where it penetrates the mitochondrial inner membrane, disrupting mitochondrial membrane potential and leading to an apoptosis-like cell death. COX9, which encodes subunit VIIa of the cytochrome c oxidase (COX) complex in the electron transport chain of the mitochondrial membrane, was identified as a potential target of miltefosine from a genomic library screen of the model yeast Saccharomyces cerevisiae. When overexpressed in S. cerevisiae, COX9, but not COX7 or COX8, led to a miltefosine-resistant phenotype. The effect of miltefosine on COX activity was assessed in cells expressing different levels of COX9. Miltefosine inhibited COX activity in a dose-dependent manner in Cox9p-positive cells. This inhibition most likely contributed to the miltefosine-induced apoptosis-like cell death.
Footnotes
↵ The online version of this article (available at http://molpharm.aspetjournals.org) contains supplemental material.
This work was supported by the National Health and Medical Research Council, Australia [Project Grant 570891] and by a Fellowship from the Sydney Medical School Foundation (to T.C.S.).
Article, publication date, and citation information can be found at http://molpharm.aspetjournals.org.
doi:10.1124/mol.111.072322.
-
ABBREVIATIONS:
- PC
- phosphatidylcholine
- PE
- phosphatidylethanolamine
- COX
- cytochrome c oxidase
- MIC
- minimum inhibitory concentration
- YPD
- yeast extract peptone dextrose
- YPGly
- yeast extract peptone glycerol
- YNB
- yeast nitrogen base
- PBS
- phosphate-buffered saline
- DiOC6
- 3,3′-dihexyloxacarbocyanine iodide
- DAPI
- 4,6-diamidino-2-phenylindole
- PI
- propidium iodide
- TUNEL
- terminal deoxynucleotidyl transferase dUTP nick-end labeling
- kb
- kilobase(s)
- PCR
- polymerase chain reaction
- qRT
- quantitative real-time
- TES
- N-tris-[hydroxymethyl]methyl-2-aminoethanesulfonic acid
- AEBSF
- 4-[2-aminoethyl]-benzene-sulfonylfluoride·HCl
- KCN
- potassium cyanide
- WT
- wild type
- FP
- forward primer
- RP
- reverse primer.
- Received March 17, 2011.
- Accepted May 24, 2011.
- Copyright © 2011 The American Society for Pharmacology and Experimental Therapeutics
MolPharm articles become freely available 12 months after publication, and remain freely available for 5 years.Non-open access articles that fall outside this five year window are available only to institutional subscribers and current ASPET members, or through the article purchase feature at the bottom of the page.
|